ReviewFrontiers in physiology2026
GDM as a unique pathophysiological entity or a transitional pregnancy-induced glucose metabolism abnormality identifying primary diabetes types?
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes mellitus is defined as glucose intolerance first diagnosed during pregnancy; however, this diagnosis may actually represent a heterogeneous spectrum of primary diabetes phenotypes unmasked by the metabolic stress of pregnancy rather than a single pathophysiological entity. The current review aims to summarise available knowledge about the diabetes spectrum in pregnancy with particular focus on its pathophysiology, risk factors and postpartum destiny. Another aim was to discuss possibilities for stratification of the women according to their immediate and future risks of postpartum persistence of glucose intolerance and its complications in later life. Specific objectives of the paper are: (1) to summarise data on physiological metabolic changes in pregnancy, (2) characterise the diabetes spectrum in pregnancy, (3) address the current state of the art in GDM diagnosis and management, (4) to summarize data on postnatal development and maturation of the infants who experienced GDM
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.